Conference News

Newborn Vitamin K Refusal Trends

Investigators examine trends in newborn vitamin K refusal and associated neurologic outcomes.

Share

Refusal of vitamin K injections for newborns is increasing, posing risks of preventable neurodevelopmental issues. This systematic review presented at the American Academy of Neurology Annual Meeting evaluates 25 studies published between 2005 and 2025 and highlights that while refusal rates in US hospitals remain below 1%, some regions show notable increases. The injection prevents vitamin K deficiency bleeding, a severe condition linked to intracerebral hemorrhage, which can lead to long-term neurological impairments. The correlation between vitamin K refusal and broader healthcare hesitancy emphasizes the need for informative prenatal counseling.

Original Source(s)

Newborn Vitamin K Refusal Trends

Investigators examine trends in newborn vitamin K refusal and associated neurologic outcomes.

  • by Kathryn Wighton

  • March 9, 2026

  • 3 min

Related Content

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Closing the Genomic Gap in Rare Disease

Ahead of Rare Disease Day, leaders from iHope and PacBio explore how technology, collaboration, and policy reform can bring accurate genomic diagnosis

  • February 27, 2026

  • 8 min
FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.